首页
400-620-6333
应用
选项
-
Recombinant Human EphB2 Protein种属: 人(Human) Accession #: P29323表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Human EphB2 Fc Chimera is coated at 2 μg/mL, Recombinant Human Ephrin-B2 Fc Chimera binds with an apparent Kd <0.1 nM.
-
Recombinant Human Nectin-4 Protein种属: 人(Human) Accession #: Q96NY8-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human Nectin-4 Protein (rp183631) at 1.0 μg/mL can bind Enfortumab vedotin-ejfv (anti-Nectin-4) (Ab175528) with the EC50 of 17.59 ng/mL.
-
Recombinant Human EphA4 Protein种属: 人(Human) Accession #: P54764表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human EphA4 Protein (rp183616) at 2.0 μg/mL can bind Human Recombinant Ephrin-A4 Protein (rp145636) with the EC50 of 8.848 ng/mL.
-
Recombinant Human EGFR Protein种属: 人(Human) Accession #: P00533表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human EGFR Protein (rp176273) at 1.0 μg/mL can bind Depatuxizumab (anti-EGFR) (Ab182750) with the EC50 of 25.83 ng/mL. Immobilized Recombinant Human EGFR Protein (rp176273) at 1.0 μg/mL can bind Depatuxizumab mafodotin (anti-EGFR) (Ab175508) with the EC50 of 28.96 ng/mL. Immobilized Recombinant Human EGFR Protein (rp176273) at 1.0 μg/mL can bind Nimotuzumab (anti-EGFR) (Ab175612) with the EC50 of 45.18 ng/mL. Immobilized Recombinant Human EGFR Protein (rp176273) at 1.0 μg/mL can bind Serclutamab (anti-EGFR) (Ab182867) with the EC50 of 35.7 ng/mL. Immobilized Recombinant Human EGFR Protein (rp176273) at 1.0 μg/mL can bind Cetuximab (anti-EGFR) (C411992) with the EC50 of 17.44 ng/mL. Immobilized Recombinant Human EGFR Protein (rp176273) at 1.0 μg/mL can bind Panitumumab (anti-EGFR) (Ab169317) with the EC50 of 23.66 ng/mL.
-
Recombinant Human Guanylyl Cyclase C/GUCY2C Protein种属: 人(Human) Accession #: P25092表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Testing in progress
-
Recombinant Human IL-12/IL-23 p40 Protein种属: 人(Human) Accession #: P29460表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human IL-12/IL-23 p40 Protein (rp181556) at 1.0 μg/mL can bind Briakinumab (anti-IL-12) (Ab175480) with the EC50 of 17.82 ng/mL.
-
Recombinant Human LAIR1 Protein种属: 人(Human) Accession #: Q6GTX8表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of HeLa human cervical epithelial carcinoma cells. The ED50 for this effect is 0.25-1.0 μg/mL.
-
Recombinant Human Siglec-8 Protein种属: 人(Human) Accession #: Q9NYZ4-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Biotinylated Sialyl Lewis X was immobilized at 0.05 μg/mL (100 μL/well), it binds Recombinant Human Siglec-8. The concentration of Human Siglec-8 that produces 50% of the optimal binding response is approximately 0.2-1.2 μg/mL.
-
Recombinant Human Nectin-2/CD112 Protein种属: 人(Human) Accession #: Q92692-2表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Human Nectin‑2/CD112 Fc Chimera is immobilized at 0.5 µg/mL (100 µL/well), the concentration of Recombinant Human DNAM‑1 Fc Chimera that produces 50% of the optimal binding response is 0.04-0.2 μg/mL.
-
Recombinant Human Siglec-15 Protein种属: 人(Human) Accession #: Q6ZMC9-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit anti-CD3 antibody induced IL-2 or IFN-gamma secretion by human T cells. The ED50 for this effect is 1-10 μg/mL.
-
Recombinant Human CD160 Protein种属: 人(Human) Accession #: O95971表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: When recombinant mouse HVEM Fc Chimera is immobilized at 0.5 μg/mL, 100 μL/well, the concentration of recombinant human CD160 that produces 50% of the optimal binding response is found to be approximately 0.1 ‑ 0.6 μg/mL.
-
Recombinant Human LILRA1/CD85i/LIR-6 Protein种属: 人(Human) Accession #: O75019-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA1/CD85i/LIR-6 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like 7/ANGPTL7 binds with an ED50 = 0.3-1.8 µg/mL.
